Search Within

Venkatraman Ennapadam Seshan

  1. "Mark Kris"
Formats
  1. Journal Article (24)
  2. Meeting Abstract (11)
Groups
  1. Biostatistics Service (35)
  2. Center for Pancreatic Cancer Research (35)
  3. Department of Medicine (35)
  4. Epidemiology and Biostatistics (35)
  5. Solid Tumor Oncology Division (35)
  6. Thoracic Oncology (35)

More Groups

People
  1. Mark Kris (35)
  2. Vincent Miller (18)
  3. Valerie Rusch (16)
  4. Christopher Azzoli (12)
  5. Maureen Zakowski (10)
  6. William Pao (10)

More People

Years
  1. 2019 (1)
  2. 2018 (1)
  3. 2016 (1)
  4. 2009 (1)
  5. 2008 (2)
  6. 2007 (7)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Journal of Thoracic Oncology (6)
  3. Annals of Thoracic Surgery (4)
  4. Cancer (4)
  5. Clinical Cancer Research (3)
  6. Cancer Chemotherapy and Pharmacology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. Elsevier Inc. (6)
  3. American Association for Cancer Research (5)
  4. Elsevier Science, Inc. (4)
  5. Wiley Blackwell (4)
  6. American College of Chest Physicians (1)

More Publishers

Results (35)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Harnessing clinical sequencing data for survival stratification of patients with metastatic lung adenocarcinomas
    Journal Article

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M.; Arbour, K. C.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Prognostic relevance of tumor sequencing in metastatic lung adenocarcinomas
    Meeting Abstract

    Shen, R.; Martin, A.; Ni, A.; Hellmann, M. D.; Jordan, E.; Arora, A.; Ptashkin, R.; Zehir, A.; Kris, M. G.; Arbour, K. C.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Next-generation sequencing of stage IV squamous cell lung cancers reveals an association of PI3K aberrations and evidence of clonal heterogeneity in patients with brain metastases
    Journal Article

    Paik, P. K.; Shen, R.; Won, H.; Rekhtman, N.; Wang, L.; Sima, C. S.; Arora, A.; Seshan, V.; Ladanyi, M.; Berger, M. F.; more...
    Cancer Discovery (2016)

    Fulltext@MSK | Save
  • Randomized phase II study of pulse erlotinib before or after carboplatin and paclitaxel in current or former smokers with advanced non-small-cell lung cancer
    Journal Article

    Riely, G. J.; Rizvi, N. A.; Kris, M. G.; Milton, D. T.; Solit, D. B.; Rosen, N.; Senturk, E.; Azzoli, C. G.; Brahmer, J. R.; Sirotnak, F. M.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components
    Journal Article

    Sarkaria, I. S.; Zakowski, M. F.; Pham, D.; Hezel, M.; Ebright, M. I.; Chuai, S.; Venkatraman, E. S.; Kris, M. G.; Rusch, V. W.; Singh, B.
    Annals of Thoracic Surgery (2008)

    Fulltext@MSK | Save
  • Prognostic and therapeutic implications of EGFR and KRAS mutations in resected lung adenocarcinoma
    Journal Article

    Marks, J. L.; Broderick, S.; Zhou, Q.; Chitale, D.; Li, A. R.; Zakowski, M. F.; Kris, M. G.; Rusch, V. W.; Azzoli, C. G.; Seshan, V. E.; more...
    Journal of Thoracic Oncology (2008)

    Fulltext@MSK | Save
  • Advanced age is associated with lack of administration of adjuvant chemotherapy for completely resected stage IB-III non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Riely, G. J.; Seshan, V. E.; Azzoli, C. G.; Kris, M. G.; Rusch, V. W.; Park, B. K.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • EGFR and KRAS mutations are molecular predictors of survival in resected lung adenocarcinoma
    Meeting Abstract

    Marks, J. L.; Broderick, S.; Seshan, V. E.; Zakowski, M. F.; Li, A.; Wilson, R.; Kris, M. G.; Ladanyi, M.; Rusch, V. W.; Pao, W.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Prospective trial of preoperative gefitinib to correlate response with EGFR exon 19 and 21 mutations and to select patients for adjuvant gefitinib
    Meeting Abstract

    Kris, M. G.; Pao, W.; Zakowski, Maureen F; Ladanyi, M.; Heelan, R. T.; Schwartz, L.; Zhao, B.; Venkatraman, E.; Rusch, V.; Rizvi, N. A.
    Journal of Thoracic Oncology (2007)

    Fulltext@MSK | Save
  • Interim results of two prospective trials measuring plasma total DNA and methylated genes before and after surgery or chemotherapy in patients with non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Azzoli, C. G.; Kobayashi, H.; Park, S.; Ginex, P.; Vincent, A.; Jones, J.; Venkatraman, E.; Danenberg, K.; Danenberg, P.; Rusch, V. R.; more...
    International Journal of Biological Markers (2007)

    Fulltext@MSK | Save